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PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel (MF-H) on 
cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained 
male cyclists completed three experimental trials consisting of a 98-min varied-intensity cycling 
protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over 
design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. The 
treatments consisted of 78 g . hr-1 of either a) MF-H, b) maltodextrin-fructose (MF), and c) 
maltodextrin only (MD) All data were assessed using repeated measures ANOVA’s. RESULTS: 
There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF, 
281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. However, mean 
power output for sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF (269 ± 2 W; 
p=0.04) and versus MF-H (270 ± 2 W; p=0.01). Subjective ratings of gastrointestinal discomfort 
symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during 
the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic 
differences in gastrointestinal discomfort symptoms observed between treatments.  
CONCLUSIONS: Ingestion of a maltodextrin/fructose hydrogel beverage improved cycling 
performance late in exercise compared to maltodextrin alone, but provided no further 
performance benefits versus a maltodextrin/fructose beverage.  In addition, the 
maltodextrin/fructose hydrogel beverage resulted no systematic benefits in gastrointestinal 
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Carbohydrates and fats are the two primary sources of fuel utilized by the muscle during 
endurance exercise, and their proportional utilization varies depending on the intensity and 
duration of the activity (Romjin et al., 1993). During low and moderate intensity exercise, fat is 
the predominant substrate oxidized, with carbohydrate utilization increasing as intensity is 
increased (Loon et al., 2001, Romjin et al., 1993). Competitive endurance athletes have a high 
reliance on carbohydrate during exercise, but have a somewhat limited carbohydrate reserve 
from endogenous sources such as liver and muscle glycogen or blood glucose (Hermansen et al., 
1967). Decreased muscle/liver glycogen and blood glucose during prolonged duration exercise 
leads to reduced carbohydrate oxidation rates, which may limit endurance performance during 
activities of approximately 2 h or longer (Coyle et al., 1986).  As such, carbohydrate ingestion, 
typically in the form of carbohydrate-electrolyte beverages, has been utilized to sustain 
carbohydrate oxidation rates, maintain higher ATP turnover, and augment performance. 
 Several studies have reported that carbohydrate ingestion during prolonged exercise has 
positive effects on endurance performance.  During exercise protocols 2 h, researchers have 
reported that carbohydrate ingestion improves time to fatigue by an average of 24.8% versus 
placebos, and time trial performance by 2-8 % (Stellingwerff & Cox 2014).  Carbohydrate intake 
during exercise has resulted in ergogenic effects with ingestion rates as low as 10 g/h, as Smith 
et al. reported a 1% improvement in cycling performance compared to placebo (Smith et al., 




during exercise have utilized ingestion rates  30 g/hr (Jentjens et al., 2004).  As such, published 
guidelines from sports nutrition groups generally recommend consuming 30 to 60 g of 
carbohydrate per hour of activity throughout prolonged endurance activities (Kreider et al., 
2010).  
There is evidence that exogenous carbohydrate oxidation rates and performance gains 
are elevated in dose-response fashion to the amount of glucose (or maltodextrin) ingested, up 
to 60 g/h (Smith et al., 2010).  It is believed that the upper-limit for this dose is limited by 
gastrointestinal uptake of glucose, which is facilitated by the sodium-glucose linked transporter 
1 (SGLT1) (Ferraris 2001).  This transporter becomes saturated at ingestion rates of 1.0 – 1.1 
g/min, preventing further uptake to the blood (and ultimately, delivery to the muscle for 
oxidation) (Jeukendrup et al., 2000, Triplett et al., 2010).  As a result, very high rates of glucose 
ingestion (> 60 g/h or 1.1 g/min) do not result in further improvements in performance and are 
also associated with increased gastrointestinal discomfort (Triplett et al., 2010). 
Although the maximum effective dose of glucose is limited by SGLT1, fructose utilizes a 
non-competitive sodium independent intestinal transporter (GLUT5), which is believed to be 
saturated at ingestion rates of 0.5 - 0.6 g/min (Currell & Jeukendrup 2008, Shi et al., 1997). Recent 
studies have reported that the combined ingestion of glucose (or maltodextrin) and fructose 
results in higher peak exogenous carbohydrate oxidation rates than glucose alone (Jentjens & 
Jeukendrup 2005; Jentjens et al., 2004a & 2004b). For example, in a review by Jeukendrup, it was 
reported that exogenous oxidation rates were significantly higher (1.26 g/min) in response to 




(Jeukendrup 2008). The resulting increase in exogenous carbohydrate oxidation with multiple 
transportable carbohydrates may be associated with sparing of endogenous carbohydrate 
reserves, which could result in higher total carbohydrate availability late in exercise, thereby 
improving performance (Jentjens & Jeukendrup 2005; Jentjens et al., 2004a & 2004b).  
The use of multiple transportable forms of carbohydrate (glucose/maltodextrin and 
fructose) can potentially improve performance more than glucose alone during moderate to high 
intensity exercise (>2 h) by increasing exogenous carbohydrate oxidation (and possibly total 
carbohydrate oxidation late in exercise) in glucose/fructose compared to glucose only trials. Two 
studies have reported superior cycling performances (approximately 8%) when high doses of 
glucose/fructose (108-144 g/h) were consumed, versus isocaloric glucose-only trials (Currell & 
Jeukendrup 2008, Triplett et al., 2010).  
Gastrointestinal distress from malabsorption of carbohydrates can interfere with 
potential ergogenic effects from carbohydrate supplementation during prolonged exercise. 
Nausea, vomiting, and other upper and lower GI tract issues have been reported extensively in 
long distance athletes (Keeffe et al., 1984, Rehrer et al., 1989). Using multiple transportable 
forms of carbohydrate may attenuate gastrointestinal distress due to having two non-
competitive transport mechanisms for carbohydrate absorption (Wilson 2015). This is supported 
by Rowlands et al., who found improvements in performance with maltodextrin-fructose 
beverages to be related to improvements in gastrointestinal discomfort (Rowlands et al., 2012). 
Additionally, another factor which may influence gastrointestinal comfort is the rate of gastric 




al., 1970).  Gastric emptying can be influenced by the concentration of carbohydrate, volume of 
fluid, caloric content, and a variety of other factors discussed in previous literature (Murray 
1987).  In an attempt to provide carbohydrate doses that optimize oxidation rates (i.e. ~ 1 g/min 
of GLU and ~ 0.5 g/min of FRUC) without gastrointestinal distress, Maurten sports drinks created 
a product utilizing hydrogels in their formula (using pectin and alginate) to promote enhanced 
gastric emptying. There are anecdotal reports that professional marathon runners have used this 
product successfully since 2016 (https://www.maurten.com/achievements). From a 
pharmacological standpoint, hydrogels have been used for drug delivery for site-specific release 
(Ahmed 2015; Hamidi 2008). Polymers containing pendant acids (carboxylic acid) such as those 
in pectin and alginate, change in accordance to their pH environment and other factors (Qiu & 
Park 2001). Due to the pH differences between the stomach and the intestines, pH-dependent 
polyelectrolyte hydrogels cause swelling of the mix in the stomach (< 3 pH), allowing controlled 
gastric emptying into the intestines where the pH is more neutral (~ 6-7) (Qiu & Park 2001).  With 
oral administration, pH-sensitive carbohydrate hydrogels can theoretically control the release of 
their contents and mitigate gastrointestinal distress by controlling the rate of gastric emptying, 
while allowing for optimal absorption of carbohydrate from the intestines.  Thus, carbohydrate 
hydrogels could theoretically provide increased carbohydrate delivery and attenuate 
gastrointestinal distress, potentially resulting in performance benefits during prolonged 
moderate to high intensity exercise (>2 h). However, no peer-reviewed studies have been 





Therefore, the purpose of this study is to determine the effects of a Maurten hydrogel 
solution containing 80g/h of maltodextrin and fructose (MF-H) on endurance performance and 
gastrointestinal comfort compared to an isocaloric maltodextrin-fructose solution (MF) and an 
isocaloric maltodextrin-only solution (MD), during a 98-min varied-load cycle test followed by a 
sprint-interval performance test (Guillochon & Rowlands 2017). We predict that MF-H will result 
in attenuated gastrointestinal distress versus MD and MF, and improved cycling performance 
versus MD, with similar performance effects versus MF.  
Assumptions, Limitations, Delimitations 
Due to the abundance of evidence suggesting exogenous carbohydrate improves 
performance through the mechanisms discussed previously, we are assuming MF-H, along with 
our other carbohydrate derivations will provide an ergogenic effect versus water alone and are 
therefore not including a placebo trial. We also assume that individuals will complete the tasks 
to the best of their ability, so we may assess variations among interventions and not from 
individual variations of performance effected by willingness, attentiveness, and other 
motivational factors.  
We are examining the effects of carbohydrate ingestion on trained cyclists. This limits our 
generalizability to only trained individuals that are performing bouts of activity that are between 
2 and 3 hours. With many studies looking at a carbohydrate intervention and exercise, our sample 
size will be limited in terms of numbers due to the lack of well-trained endurance athletes willing 




Delimitations of this study include using cyclists to assess the ergogenic effects of the 
aforementioned carbohydrate beverages. This limits our study to only being able to apply our 
data that we find to trained cyclists that are performance 2 to 3-hour bouts of activity. To provide 
sufficient controls for our study, we are standardizing the time of fasting and nutrient intake prior 
to testing, as well as time of day to better understand the carbohydrates effect on prolonged 
exercise.  
Definition of Terms 
There are several definitions that require clarification as they relate to the data outcomes 
for the present study. First, fatigue is defined as the volitional withdrawal of the exercise 
intervention or an individual’s inability to further perform the given task due to excessive 
exhaustion.  Gastrointestinal distress will be defined by assessing ratings of gut discomfort, 
including the degree of sensations indicating likelihood of nausea, stomach fullness, or abdominal 
cramping.  We define trained cyclists as individuals completing  3 d/wk of cycling, and a VO2max 












Eleven endurance-trained male cyclists were recruited from the areas of Harrisonburg, 
VA and Elon, NC to participate in this study. Inclusion criteria were: males aged 18 to 45 years of 
age, cycling  3 d . wk for three months prior to the study, with a VO2max  50 ml.kg-1.min, and 
competing regularly ( 3 years of competitive cycling or training). Exclusion criterion for this study 
were: smokers (current or former), failure to meet inclusion requirements, and intolerance to 
testing procedures. Subjects were provided with information about study procedures and risks 
and provided consent to participate prior to initiating the study. This study was approved by the 
Institutional Review Boards of James Madison University and Elon University. 
Research Design 
The study was a randomized, double-blinded, crossover design to test the effects of three 
carbohydrate beverages on performance, metabolic physiology, and gastrointestinal distress. 
Trials were separated by 3-7 days with subjects receiving standardized diet and exercise 
instructions. Trials were conducted at a consistent time of day to control variability within 
subjects. Subjects underwent four trials 1) preliminary testing and familiarization trial, 2-4) 
experimental trials with one of three carbohydrate interventions. Each trial consisted of a pre-
loaded varied-intensity protocol of 98 min, followed immediately by a performance test to 





Preliminary testing and familiarization trial 
Before any experimental trials were conducted, participants underwent a graded exercise 
test on a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA) to determine maximal oxygen 
consumption (VO2max) and maximal power output (Wmax) using a protocol described previously 
(Triplett et al., 2010; Kreider et al., 2010). After a 10-min warm-up at 100 W, subjects began the 
test at a pre-determined wattage based on body weight (W = 3*subject BW (kg)).   Power output 
was then increased by 25W every 2-min until volitional exhaustion. Metabolic responses during 
each stage was recorded using a Parvo Medics TrueOne 2400 (Parvo Medics, Sandy, UT). VO2max 
was determined by the highest 30 s mean oxygen uptake value. Following the VO2max trial, 
subjects were given 5-min rest, followed by a familiarization with the last 60-min of the pre-load 
protocol and the performance test.    
Diet and exercise control 
Subjects were instructed to 1) maintain consistent diet and training in the 72 h prior to each 
performance trials, 2) engage in a 90-min moderate intensity ride 48 h prior to performance trial, 
3) record food intake and physical activity for 24 h prior to first experimental trial, 4) repeat food 
intake from recorded data in subsequent trials, 5) rest from exercise for 24 h leading to trial, and 
6) refrain from consuming alcohol and caffeine for 24 h and 12 h, respectively, prior to trials (Fig 
1). Subjects were all fed during performance trials as shown in Figure 2. Two hours prior to trials, 
subjects consumed standard meals consisting of a Clif Energy Bar (Clif Bar & Company; 









As shown in Figure 2, subjects completed a 98 min pre-load trial to simulate a cycling road 
race using a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA).  This trial consisted of 60-
min of constant-load exercise at 50% Wmax followed by eight, 2-min intervals at 80% Wmax. Rest 
intervals were performed at 50% of Wmax and lasted 2 min, except for a 5-min rest interval 
between the the fourth and fifth work interval (Coggan & Coyle 1987). Following the 98-min 
protocol, subjects performed a performance test consisting of ten sprints. Subjects were 
instructed to give maximal efforts with each sprint and subsequent recovery until a 




weight in kilograms (Wmax * 0.125).  Sprints were designed to be approximately 2-3 min in length 
with the rest period (40% Wmax) lasting approximately 5 min. During the sprints, subject’s power 
output data was withheld to prevent pacing versus other trials. Power output, time to complete 
sprints and rest periods were collected in addition to any physiological data and perceptual 
responses collected throughout the study duration.  
Figure 2.  Overview of Exercise Trial and Measurements  
 
Physiological measurements 
Heart rate (Polar Electro Inc.; Bethpage, NY) was recorded every 15 min, and at test 




a PARVO Metabolic System (PARVO Medics; Sandy, UT) at minutes 15-20, 45-50, and 93-98 
during the pre-load phase, and at minutes 160-165 during the performance trial (Fig 2). Finger 
stick blood samples (0.5 mL) were obtained at the following time intervals: prior to exercise, at 
minutes 45, 98, and 160, and immediately following the performance test (Fig. 2). Lactate and 
glucose levels were assessed from whole blood using automated instrumentation (YSI 2900D 
Biochemistry analyzer YSI Life Sciences, Yellow Springs, OH).  
Perceptual Responses and Gastrointestinal Distress Scale 
Gastrointestinal distress symptoms and perceived exertion responses were indicated in 
writing at every 15-min interval (fig. 2) using a 100-point scale (i.e. 1 = no GI distress; 100 = 
absolute maximum) adapted from Jentjens et al. (2002). Subjects were instructed to draw a line 
across the scale every time interval to indicate their symptoms. Subjects rated symptoms 
including: nausea, fullness, and abdominal cramping, in addition to effort of cycling, tiredness, 
and leg strength.  A ruler with mm increments was used to measure ratings for each variable. 
Treatments  
Subjects received 250 mL of treatment beverage immediately prior to the exercise trials, 
and 250 mL every 15-min of exercise.  Participants consumed 78 g . hr-1 (1.3  g . min-1), and 1000 
mL/hr fluid (7.8% concentration) or 3000 mL total over a 3 h period during all trials.  Treatments 
consisted of either a) Maltodextrin-fructose hydrogel (MF-H) (Maurten AB, Gothenburg, 
Sweden), providing 78 g of carbohydrate (from maltodextrin and fructose), using Maurten’s 
proprietary 160 mix (two sachets), b) maltodextrin-fructose (MF) beverage providing 




c) maltodextrin (MD) beverage providing 78 g of carbohydrate with maltodextrin only. Each 
beverage was made using spring water (Deer Park Spring Water, Nestlé Waters North America), 
and included 800 mg sodium (Morton salt; Chicago, IL) per liter, with the exception of the 
Maurten beverage, which was mixed using manufacturer’s recommendations. Treatments were 
randomized and double-blinded. 
Statistical analysis 
Statistical analyses were performed using Statistical Package for the Social Sciences 
(SPSS).  Mean values and standard deviations were calculated and reported for all dependent 
measures discussed above.  Treatment differences in these variables were assessed using 
repeated measures ANOVA’s, with individual treatment comparisons performed with Fisher’s 
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PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel (MF-H) on 
cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained 
male cyclists completed three experimental trials consisting of a 98-min varied-intensity cycling 
protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over 
design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. The 
treatments consisted of 78 g . hr-1 of either a) MF-H, b) maltodextrin-fructose (MF), and c) 
maltodextrin only (MD) All data were assessed using repeated measures ANOVA’s. RESULTS: 
There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF, 
281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. However, mean 
power output for sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF (269 ± 2 W; 
p=0.04) and versus MF-H (270 ± 2 W; p=0.01). Subjective ratings of gastrointestinal discomfort 
symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during 
the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic 
differences in gastrointestinal discomfort symptoms observed between treatments.  
CONCLUSIONS: Ingestion of a maltodextrin/fructose hydrogel beverage improved cycling 
performance late in exercise compared to maltodextrin alone, but provided no further 
performance benefits versus a maltodextrin/fructose beverage.  In addition, the 
maltodextrin/fructose hydrogel beverage resulted no systematic benefits in gastrointestinal 






Competitive endurance athletes utilize carbohydrate extensively during exercise, but 
have limited endogenous carbohydrate reserves from liver/muscle glycogen and blood glucose 
(Hermansen et al., 1967). Decreased muscle/liver glycogen and blood glucose during prolonged 
exercise leads to reduced carbohydrate oxidation rates, which may limit endurance performance 
during activities ~ 2 h or longer (Coyle et al., 1986).  Importantly, the ingestion of carbohydrate 
beverages during prolonged exercise has been shown to sustain carbohydrate oxidation rates, 
maintain higher ATP turnover, and augment performance. 
 Numerous studies have reported that carbohydrate ingestion during prolonged exercise 
has positive effects on performance.  Sports nutrition guidelines generally recommend 
consuming 30 - 60 g/h of carbohydrate throughout prolonged endurance activities (Kreider et al., 
2010). However, there is evidence that exogenous carbohydrate oxidation rates and 
performance gains are elevated in dose-response fashion to the amount of glucose/maltodextrin 
ingested, up to 60 g/h (Smith et al., 2010).  Carbohydrate intake beyond 60 g/h can lead to 
gastrointestinal (GI) distress from malabsorption of carbohydrates, consequently interfering with 
the potential ergogenic effects of carbohydrate supplementation. Indeed, nausea, vomiting, and 
other upper and lower GI tract issues have been reported extensively in long distance athletes 
(Keeffe et al., 1984, Rehrer et al., 1989). A novel strategy to optimize performance gains while 
minimizing GI discomfort is the use of multiple transportable forms of carbohydrate which utilize 
non-competitive transport mechanisms for carbohydrate absorption (Wilson 2015). The 
ingestion of multiple carbohydrate types, which utilize non-competitive gastrointestinal (GI) 




endurance exercise (Smith, 2013), resulting in greater ergogenic effects compared to ingestion 
of just glucose alone (i.e. Currell & Jeukendrup, 2008; Tripplett et al., 2010).  
In an attempt to maximize carbohydrate intake without GI distress, Maurten sports drinks 
created a product utilizing hydrogels to enhance gastric emptying.  Polymers containing pendant 
acids (i.e. carboxylic acid, such as in pectin and alginate) change in accordance to their pH 
environment and other factors (Qiu & Park 2001).  Due to the pH differences between the 
stomach and intestines, pH-dependent polyelectrolyte hydrogels reportedly cause swelling of the 
mix in the stomach, allowing controlled gastric emptying into the intestines where the pH is more 
neutral (Qiu & Park 2001). Anecdotal reports suggest that some professional marathon runners 
have used this product successfully since 2016, and it has recently been marketed to competitive 
cyclists (https://www.maurten.com/achievements).  However, no peer-reviewed studies have 
examined the effects of carbohydrate hydrogel ingestion on carbohydrate delivery and 
endurance performance.  
Therefore, the purpose of this study was to determine the effects of a Maurten hydrogel 
solution containing 78 g/h of maltodextrin and fructose (MF-H) on endurance performance and 
GI comfort compared to an isocaloric maltodextrin-fructose solution (MF) and an isocaloric 
maltodextrin-only solution (MD), during a 98-min varied-load cycle test followed by a sprint-
interval performance test (Guillochon & Rowlands 2017). We hypothesize that MF-H will result 
in attenuated GI distress versus MD, but not MF, and improved cycling performance versus MD, 






Eleven endurance-trained male cyclists were recruited from the areas of Harrisonburg, 
VA and Elon, NC to participate in this study. Inclusion criteria were: males aged 18 to 45 years of 
age, cycling  3 d . wk for three months prior to the study, with a VO2max  50 ml.kg-1.min, and 
competing regularly ( 3 years of competitive cycling or training). Exclusion criterion for this study 
were: smokers (current or former), failure to meet inclusion requirements, and intolerance to 
testing procedures. Subjects were provided with information about study procedures and risks 
and provided consent to participate prior to initiating the study. This study was approved by the 
Institutional Review Boards of James Madison University and Elon University. 
Research Design 
The study was a randomized, double-blinded, crossover design to test the effects of three 
carbohydrate beverages on performance, metabolic physiology, and gastrointestinal distress. 
Trials were separated by 3-7 days with subjects receiving standardized diet and exercise 
instructions. Trials were conducted at a consistent time of day to control variability within 
subjects. Subjects underwent four trials 1) preliminary testing and familiarization trial, 2-4) 
experimental trials with one of three carbohydrate interventions. Each trial consisted of a pre-
loaded varied-intensity protocol of 98 min, followed immediately by a performance test to 





Preliminary testing and familiarization trial 
Before any experimental trials were conducted, participants underwent a graded exercise 
test on a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA) to determine maximal oxygen 
consumption (VO2max) and maximal power output (Wmax) using a protocol described previously 
(Triplett et al., 2010; Kreider et al., 2010). After a 10-min warm-up at 100 W, subjects began the 
test at a pre-determined wattage based on body weight [W = 3*subject BW (kg)].   Power output 
was then increased by 25W every 2-min until volitional exhaustion. Metabolic responses during 
each stage was recorded using a Parvo Medics TrueOne 2400 (Parvo Medics, Sandy, UT). VO2max 
was determined by the highest 30 s mean oxygen uptake value. Following the VO2max trial, 
subjects were given 5-min rest, followed by a familiarization with the last 60-min of the pre-load 
protocol and the performance test.    
Diet and exercise control 
Subjects were instructed to 1) maintain consistent diet and training in the 72 h prior to 
each performance trials, 2) engage in a 90-min moderate intensity ride 48 h prior to performance 
trial, 3) record food intake and physical activity for 24 h prior to first experimental trial, 4) repeat 
food intake from recorded data in subsequent trials, 5) rest from exercise for 24 h leading to trial, 
and 6) refrain from consuming alcohol and caffeine for 24 h and 12 h, respectively, prior to trials 
(Fig 1). Subjects were all fed during performance trials as shown in Figure 2. Two hours prior to 
trials, subjects consumed standard meals consisting of a Clif Energy Bar (Clif Bar & Company; 











As shown in Figure 2, subjects completed a 98 min pre-load trial to simulate a cycling road 
race using a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA).  This trial consisted of 60-
min of constant-load exercise at 50% Wmax followed by eight, 2-min intervals at 80% Wmax. Rest 
intervals were performed at 50% of Wmax and lasted 2 min, except for a 5-min rest interval 
between the fourth and fifth work interval (Coggan & Coyle 1987). Following the 98-min protocol, 
subjects performed a performance test consisting of ten sprints. Subjects were instructed to give 




requirement was met, based on the subject’s wattage at max and body weight in kilograms (Wmax 
* 0.125). Sprints were designed to be approximately 2-3 min in length with the rest period (40% 
Wmax) lasting approximately 5 min. During the sprints, subject’s power output data was withheld 
to prevent pacing versus other trials. Power output, time to complete sprints and rest periods 
were collected in addition to any physiological data and perceptual responses collected 
throughout the study duration.  







Heart rate (Polar Electro Inc.; Bethpage, NY) was recorded every 15 min, and at test 
termination (Fig. 2). Oxygen uptake (VO2) respiratory exchange ratio (RER) were assessed using 
a PARVO Metabolic System (PARVO Medics; Sandy, UT) at minutes 15-20, 45-50, and 93-98 
during the pre-load phase, and at minutes 160-165 during the performance trial (Fig 2). Finger 
stick blood samples (0.5 mL) were obtained at the following time intervals: prior to exercise, at 
minutes 45, 98, and 160, and immediately following the performance test (Fig. 2). Lactate and 
glucose levels were assessed from whole blood using automated instrumentation (YSI 2900D 
Biochemistry analyzer YSI Life Sciences, Yellow Springs, OH).  
Perceptual Responses and Gastrointestinal Distress Scale 
Gastrointestinal distress symptoms and perceived exertion responses were indicated in 
writing at every 15-min interval (fig. 2) using a 100-point scale (i.e. 1 = no GI distress; 100 = 
absolute maximum) adapted from Jentjens et al. (2002). Subjects were instructed to draw a line 
across the scale every time interval to indicate their symptoms. Subjects rated symptoms 
including: nausea, fullness, and abdominal cramping, in addition to effort of cycling, tiredness, 
and leg strength.  A ruler with mm increments was used to measure ratings for each variable. 
Treatments  
Subjects received 250 mL of treatment beverage immediately prior to the exercise trials, 
and 250 mL every 15-min of exercise.  Participants consumed 78 g . hr-1 (1.3  g . min-1), and 1000 




consisted of either a) Maltodextrin-fructose hydrogel (MF-H) (Maurten AB, Gothenburg, 
Sweden), providing 78 g of carbohydrate (from maltodextrin and fructose), using Maurten’s 
proprietary 160 mix (two sachets), b) maltodextrin-fructose (MF) beverage providing 
maltodextrin and fructose (Tate and Lyle, Decatur, IL) in a 3:1 ratio with 78 g total carbohydrate, 
c) maltodextrin (MD) beverage providing 78 g of carbohydrate with maltodextrin only. Each 
beverage was made using spring water (Deer Park Spring Water, Nestlé Waters North America), 
and included 800 mg sodium (Morton salt; Chicago, IL) per liter, with the exception of the 
Maurten beverage, which was mixed using manufacturer’s recommendations. Treatments were 
double-blinded and provided in a randomly-counterbalanced order. 
Statistical analysis 
Statistical analyses were performed using Statistical Package for the Social Sciences 
(SPSS).  Mean values and standard deviations were calculated and reported for all dependent 
measures discussed above.  Treatment differences in these variables were assessed using 
repeated measures ANOVA’s, with individual treatment comparisons performed with Fisher’s 









Eleven trained male cyclists (VO2max ≥ 50 ml.kg-1.min) from James Madison University and 
Elon University enrolled in this study. Nine of the eleven subjects completed the study, as one 
withdrew due to an injury unrelated to the study, and another failed to complete an experimental 
trial.  Subject demographics are displayed in Table 1.  
Table 1. Descriptive data of subjects (n=9); Mean ± SD 
Age Weight (kg) Peak VO2 (mL.kg-1.min) Peak Power (W) Years Racing 
26.1 ± 6.6 80.9 ± 10.4 55.5 ± 3.6 356 ± 39 4.8 ± 3.2 
 
Physiological Responses 
Physiological responses during the cycling trials (VO2, RER, heart rate, blood glucose, and 
blood lactate) are displayed in Table 2. During the pre-load trials, VO2 was higher in the MF-H 
treatment than MD at 15-min (p=0.025). There were no other treatment differences observed 
during the pre-load trials. During the sprint-interval trials, blood glucose was higher in the MF 
trial versus MD (p=0.044), with no other treatment difference in physiological responses. Data 
for lactate and glucose are reported for only eight subjects due to instrumentation errors during 
the exercise trials. 
Subjective Ratings 
Subjective rating scores (mean ± SD) for effort, tiredness and leg strength during cycling 
are displayed in Table 3.  Ratings of effort and tiredness were generally ≤ 50mm (less than a 
‘moderate’ rating) during the pre-load trials. Ratings of effort increased significantly over time 




Table 2. Physiological Responses During the Cycling Protocol 
Variable Treatment Mean ± SD 
VO2 
(mL.min-1) 
 15-min 45-min 90-min Sprint-7 
MF 2476 ± 225 2486 ± 204 2725 ± 213 2325 ± 262 
MF-H 2528 ± 191* 2622 ± 204 2740 ± 226 2302 ± 281 
MD 2392 ± 232 2457 ± 248 2677 ± 270 2269 ± 158 
RER 
MF 0.92 ± 0.07 0.93 ± 0.08 0.92 ± 0.06 0.91 ± 0.06 
MF-H 0.93 ± 0.05 0.93 ± 0.06 0.94 ± 0.06 0.91 ± 0.05 
MD 0.92 ± 0.07 0.92 ± 0.07 0.92 ± 0.06 0.91 ± 0.07 
Heart Rate 
(bpm) 
MF 131 ± 8 132 ± 6 145 ± 11 166 ± 7 
MF-H 132 ± 10 134 ± 11 145 ± 11 166 ± 6 
MD 131 ± 10 133 ± 9 145 ± 13 167 ± 8 
Glucose 
(mg/dL) 
MF 77.6 ± 7.9 86.7 ± 8.3 80.8 ± 10.4 87.5 ± 12.9* 
MF-H 74.7 ± 13.3 87.4 ± 10.9 85.2 ± 11.4 88.9 ± 12.6 
MD 76.1 ± 8.9 88.5 ± 14.3 84.9 ± 14.0 81.9 ± 8.6 
Lactate 
(mmol/L) 
MF 0.97 ± 0.39 0.91 ± 0.37 2.76 ± 2.52 3.36 ± 3.14 
 MF-H 0.98 ± 0.39 1.02 ± 0.31 3.01 ± 2.30 3.26 ± 2.44 
 MD 1.04 ± 0.38 1.78 ± 2.85 2.84 ± 2.06 3.42 ± 2.55 
Data are displayed as mean ± SD. 
MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; 
MD (maltodextrin-only) 1.33 g.min-1 
*Denotes significant difference in comparison to MD 
 
(≥ 67mm in all trials; ‘strong’ to ‘very strong’).  There were no significant treatment-effects or 
treatment x time interactions for effort ratings.  Similarly, tiredness ratings increased to ≥ 67mm 
(‘strong’ to ‘very strong’) across all trials with no systematic differences between treatments.  
Perceived leg strength was ≥ 67 mm (‘strong’ or greater) during the pre-load trials, and ≤ 50 mm 
(‘moderate’ to ‘weak or mild’) during the performance trial. No significant differences between 
treatments were observed for tiredness or leg strength, though all ratings increased significantly 




Table 3. Subjective Ratings of Effort, Tiredness, and Leg Strength During Cycling 







 15-min 45-min 90-min Sprint-7 
MF 29.9 ± 21.9 34.2 ± 19.2 53.7 ± 17.2 75.1 ± 14.6 
MF-H 26.5 ± 13.9 34.9 ± 16.9 52.3 ± 15.3 72.2 ± 15.2 
MD 20.3 ± 15.3 29.8 ± 16.3 46.3 ± 11.6 75.6 ± 13.1 
Tiredness 
(0-100 mm) 
MF 19.3 ± 14.4 29.8 ± 16.2 51.5 ± 18.7 72.6 ± 11.5 
MF-H 14.9 ± 9.4 27.4 ± 15.4 49.4 ± 14.6 70.4 ± 9.7 
MD 16.5 ± 13.8 27.5 ± 13.7 46.9 ± 12.5 70.6 ± 14.3 
Leg Strength 
(0-100 mm) 
MF 79.4 ± 11.1 74.3 ± 10.5 58.1 ± 15.4 35.9 ± 14.8 
MF-H 81.4 ± 9.4 75.1 ± 8.2 60.8 ± 11.3 43.3 ± 12.3 
MD 83.2 ± 10.5 77.1 ± 7.6 58.6 ± 6.6 36.4 ± 9.9 
Data are represented as mean ± SD. MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin +  
fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only) 1.33 g.min-1 
 
Gastrointestinal distress symptoms 
GI symptoms (nausea, fullness, and abdominal cramping) are shown in Figures 3-5, 
respectively.  In general, GI symptoms increased over time (p < 0.05 for all symptoms).  Symptoms 
increased from ‘extremely weak’ (≤ 10 mm) at the onset of exercise to ‘weak or mild’ (≤ 30 mm) 
by the end of the pre-load trials. Despite further increases in symptoms during the sprint 
intervals, average values did not surpass ‘moderate’ ratings of discomfort.  Individual responses 
resulted in varied degrees of GI distress, and individual GI distress symptoms exceeding moderate 
(≥ 50) and severe discomfort (≥ 65) are shown for each treatment in Table 4. 
No significant treatment x time interactions were observed for any GI symptoms. 
However, nausea ratings at 45 min were higher in MF-H versus MF (p=0.016).  Stomach fullness 
ratings at 30 min were higher in MF-H compared to MD (p=0.046) and MF (p=0.005), and stomach 





Figure 3. Effect of CHO beverages on nausea ratings across all time points 
 
 
Data are displayed as mean ± SE.  Significant main-effect for time (p < 0.05).  MF (maltodextrin + 
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only) 
1.33 g.min-1. *p < 0.05; MF vs. MF-H. 
 
Figure 4. Effect of CHO beverages on fullness ratings across all time points 
 
 
Data are displayed as mean ± SE.  Significant main-effect for time (p < 0.05).  MF (maltodextrin + 
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only) 
















































Figure 5. Effect of CHO beverages on abdominal cramping ratings across all time points 
  
 
Data are displayed as mean ± SE.  Significant main-effect for time (p < 0.05).  MF (maltodextrin + 
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only) 
1.33 g.min-1.  
 
 
Table 4. GI distress symptom incidences of moderate (m; ≥ 50) and severe discomfort (S; ≥ 65). 
Nausea 
 
15-min 30-min 45-min 60-min 75-min 90-min SPR1 SPR4 SPR7 END 
MF      1m 1m 1s 1s 1s 
MF-H       1m 2m/1s 1s 2s 
MD       1m 2m/1s 1m/2s 3s 
Fullness 
MF    1m 1m 1s 1m 1m 1m/1s 1m/1s 
MF-H       2m 2m/1s 3m/1s 2m/2s 
MD       1m 2m 1m/2s 1m/2s 
Abdominal cramping 
MF    1m 1m 1m 1s 1m/1s 1m 1m 
MF-H        1m 1m/1s 1m/1s 
MD        1m 1m  
MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 




































Average power output over the 10 sprint intervals was not significantly different 
between MF (281 ± 46 W), MF-H (284 ± 51 W) and MD (277 ± 48 W). In addition, average 
power output during recovery periods between sprints was the same between MF (140 ± 13 
W), MF-H (139 ± 14 W), and MD (139 ± 13 W).  Sprint power output during individual sprint 
intervals is illustrated in Figure 6. There were no significant between-treatment differences in 
power output any individual sprint. However, there was a visual trend suggesting a tendency 
for power output to be lower in the MD trial during the latter stages of the sprint trial, and 
power output averaged over sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF 





Figure 6. Power Output during Sprint Intervals for Each Treatment  
MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1; MD 

































The primary goal of this study was to determine the effects of a MF-H beverage on 
endurance cycling performance and GI comfort ratings compared to MF and MD beverages, 
matched for carbohydrate/caloric content.  To our knowledge, this is the first study examining 
the effects of carbohydrate hydrogels on these outcomes.  Although ingestion of MF-H had no 
significant effects on average power output over the entire sprint interval test, both MF-H and 
MF provided greater sprint power over the final four sprints of the performance trial compared 
to MD.  No differences in performance were observed between MF-H and MF beverages.  GI 
distress symptoms increased throughout the duration of each trial, but there were no 
systematically different ratings of GI symptoms between treatments, particularly late in exercise.  
We observed no differential effects of the beverages on average sprint performance in 
the present study (differences between MF-H/MF versus MD were 1.4/2.5%, respectively; N.S.).  
However, power output averaged over the final four sprints was ~ 4% higher (p < 0.05) in the 
beverages containing a mix of maltodextrin and fructose (MF-H and MF) versus maltodextrin 
alone.  This observation is generally consistent with prior studies examining the effects of 
multiple transportable carbohydrate beverages (i.e. glucose/maltodextrin + fructose) on 
performance.  For example, Currell and Jeukendrup (2008) examined endurance performance 
during a one-hour time trial that immediately followed 2 h of constant-load cycling, and reported 
that average power output was 8.1% higher when subjects consumed glucose+fructose versus 
an isocaloric amount of glucose alone.  Similarly, Tripplett et al. (2010) found that average power 




versus an isocaloric glucose-only beverage.  The large ergogenic effects reported in these studies 
may have been due to substantially higher carbohydrate ingestion rates (108 – 144 g/h) than the 
present study (78 g/h), which could have magnified the potential effects of glucose+fructose on 
exogenous carbohydrate oxidation (discussed below), or exacerbated ergolytic effects of 
excessive glucose in the glucose-only trials.  In support of this concept, Baur and colleagues 
(2014) reported that maltodextrin+fructose ingestion improved cycling time-trial performance 
by 3.0 % compared to an isocaloric maltodextrin-only beverage (93 g/h); this effect was reduced 
to 1.2 % when compared to a lower rate of maltodextrin intake (60 g/h).  Similarly, Rowlands et 
al (2012) found only modest improvements in cycling time-trial performance (1.8 %) and average 
sprint power (1.4%) when comparing maltodextrin+fructose versus maltodextrin/glucose 
beverages, when consumed at intake rates similar to the present study (~ 80 g/h).  Therefore, 
our findings support the existing literature, suggesting that the consumption of multiple 
transportable carbohydrates provides modest ergogenic effects in comparison to single 
carbohydrate sources.  However, our primary purpose was to determine if carbohydrate 
hydrogels influence performance versus conventional carbohydrate beverages.  Although 
ingestion of MF-H improved late-exercise performance compared to MD, MF-H did not provide 
further benefits in comparison to MF. Our findings suggest that carbohydrate hydrogels do not 
affect cycling performance to a greater extent than conventional beverages with the same 
carbohydrate composition.   
It is generally believed that the ergogenic effects of multiple transportable carbohydrates 
are due to influences on a) total carbohydrate oxidation, and/or b) gastrointestinal comfort. 




of 60 g . hr-1 or 1 g . min-1 (Jeukendrup and Jentjens 2000). Ingestion of higher rates of a single 
form of carbohydrate does not increase exogenous oxidation and is likely to be associated with 
increased incidences of GI distress. This is because the intestines absorb glucose/maltodextrin 
via the sodium-dependent glucose transporter 1 (SGT1) at a maximal rate ~1.0 to 1.1 g . min-1 
(Jeukendrup et al., 2000). However, intestinal uptake of fructose occurs via the sodium-
independent transporter (GLUT5) which is a non-competitive uptake pathway to that of glucose 
(Shi et al., 1997), at a rate of ~0.6 g . min-1 (Jeukendrup et al., 2004). Combining multiple 
transportable carbohydrates has been reported to increase total carbohydrate oxidation rates 
compared to single carbohydrate sources (Jentjens et al., 2004).  The increase in exogenous 
carbohydrate oxidation is generally believed to be beneficial due to a decreased reliance on 
endogenous carbohydrate sources – mainly from the sparing of hepatic glycogen (Jentjens & 
Jeukendrup 2005; Wallis et al., 2005).  This could result in higher total carbohydrate oxidation 
rates (exogenous + endogenous), supporting higher power output in the latter stages of 
prolonged exercise.  However, most metabolic responses between trials in this study were similar 
between all treatments.  It is worth noting that blood glucose levels during the sprint-intervals 
was higher in the MF/MF-H trials (88/89 mg/dL) versus MD (82 mg/dL) providing some evidence 
that carbohydrate availability may have been augmented in the MF/MF-H trials.  However, we 
observed no differences in RER (indicative of carbohydrate/fat utilization) between treatments 
at any timepoint in the study.  In addition, there were no differences in blood lactate values, 
which could augment carbohydrate oxidation late in exercise (Lecoultre et al., 2010; Jentjens et 
al., 2004). The lack of compelling evidence for elevated carbohydrate oxidation rates is in line 




glucose/maltodextrin (i.e. Baur et al., 2014; Currell and Jeukendrup, 2008; Rowlands et al., 2012; 
Tripplett et al, 2010), thereby necessitating more data to confirm the mechanisms for superior 
performance.             
The ergogenic effects of glucose/maltodextrin + fructose could also be related to 
influences on GI tolerance (Baur et al., 2014; Rowlands et al., 2012).  As discussed previously, 
excessive glucose ingestion rates (and the associated effects on GI intolerance) could potentially 
explain large performance effects reported for glucose + fructose beverages in some studies 
(Currell and Jeukendrup, 2008; Tripplett et al., 2010).  However, similar to Baur et al. (2014), we 
observed no systematic reduction in GI discomfort symptoms during cycling with MF versus MD, 
so we cannot directly associate the observed improvements in late-exercise power output with 
influences on GI comfort.  In addition, contrary to anecdotal reports, we observed no positive 
effects of MF-H on GI distress symptoms such as nausea, fullness and abdominal cramping.  In 
fact, some measures of GI discomfort were higher in MF-H than other beverages during the pre-
load trials (i.e. nausea ratings at 45-min, fullness ratings at 30, 60 & 75 min).  However, we 
conclude that any negative effects of MF-H on GI discomfort were trivial, as discomfort ratings at 
these times were low (below ‘moderate’) and treatment differences did not persist into the later 
stages of exercise, where discomfort ratings were higher and more likely to affect performance.  
Therefore, we observed no systematic effects of MF or MF-H on GI discomfort.  However, it is 
worth noting that GI discomfort is influenced by a variety of exercise factors, such as intensity, 
duration, mode of exercise, and environmental conditions (Rehrer et al., 1994).  In the present 
study (cycling exercise in a controlled environment at room temperature), the mean ratings for 




influence on performance for most individuals under these conditions.  Very few individuals 
reported any ‘severe’ symptoms (≥ 65) at any time-point, but it could be instructive that the 
highest number of severe symptoms were reported in the MD trial (3 for nausea; versus 2/1 for 
MF-H/MF respectively).  Therefore, it could be useful to further examine the effects of MF and 
MF-H on GI discomfort under exercise conditions that elicit more severe GI distress symptoms.      
The present study utilized trained cyclists as subjects to determine the efficacy of a 
carbohydrate hydrogel on improvements in performance and GI distress during prolonged 
exercise.  Our study design utilized a sprint interval protocol in order to examine the effects of 
carbohydrates on performance, and better replicate high-intensity efforts experienced during 
cycling competitions. Additionally, GI distress is more commonly associated with high intensity 
exercise, as illustrated by higher ratings of GI symptoms during the sprint interval segment of the 
test.  Though there were no observed benefits of MF-H over MF, future studies should consider 
the influences of exercise modality and carbohydrate doses to determine whether MF-H 
influences endurance performance and GI distress under different conditions.  Larger sample 
sizes would also provide greater statistical power to assess potentially small effects of 
carbohydrate hydrogels on endurance performance. 
In conclusion, we observed that carbohydrate beverages with maltodextrin + fructose 
(MF and MF-H) improved late-exercise sprint performance versus MD alone.  However, MF-H 
provided no further benefits on performance versus MF.  In addition, MF-H had no positive 
effects on GI symptoms versus MF or MD.  Therefore, our findings refute anecdotal reports that 
MF-H beverages reduce GI discomfort and improve endurance performance.  It remains to be 




a) at higher dosages (≥ 1.3 g . min-1), or b) during exercise conditions that elicit more severe levels 
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